|
Site Search
|
WuXi PharmaTech Reports Higher Q4 and 2007 Financials
publication date: Mar 12, 2008
WuXi PharmaTech reported that its Q4 revenues were up 64% over the year earlier, coming in at $37.1 million. Net income more than tripled, rising 205.7% to $12.1 million. The numbers mean that earnings per ADS were 17 cents, fully diluted. WuXi also forecast much higher revenues of $280 million to $300 million in 2008, though this includes revenue from the AppTec acquisition. More details...
Stock Symbol: (NYSE: WX)
|
Partner Events
October 11-13, 2008
Dalian, China
U.S. FDA Inspections in China
October 15, 2008
China
November 8, 2008
San Diego, CA
November 9-11, 2008
Shanghai, China
February 23-25, 2009
San Diego
>> More details...
|
